4 FDA actions
COSENTYX (SECUKINUMAB)
NOVARTIS PHARMS CORP
BEOVU (BROLUCIZUMAB)
ADAKVEO (CRIZANLIZUMAB)
ENTRESTO (SACUBITRIL AND VALSARTAN)